Rare Disease Patient Recruitment Services - MedPanel
rare disease market research analysis rare disease market growth chart rare diseases research infographic

Rare disease patient recruitment for market research and clinical studies

In short, verified patients, caregivers, and clinicians — recruited with HIPAA-, GDPR-, and ISO 20252-aligned protocols.

What to expect at a glance

  • First, 3–5 business days: typical turnaround for a feasibility assessment.
  • Next, 2–4 weeks: common recruitment window after kickoff (varies by incidence and criteria).
  • Finally, compliance: HIPAA and GDPR safeguards plus ISO 20252–certified processes.

Rare disease patient recruitment plays a key role in successful market research and clinical studies. MedPanel connects researchers with verified patients, caregivers, and healthcare professionals across the globe, making recruitment faster and more reliable.

Additionally, for adjacent capabilities, explore healthcare research methods, review patient recruitment services, or browse the case studies library.

Why rare disease recruitment is different

For example, in the United States, a condition is considered rare when it affects fewer than 200,000 people. Consequently, populations stay small, geographically dispersed, and frequently diagnosed late compared with common diseases.

By contrast, traditional outreach and broad consumer panels often miss incidence entirely. Therefore, at MedPanel, rare disease recruitment is treated as a core competency rather than an add-on.

In particular, physician partners who see rare disease patients daily anchor sourcing efforts. Likewise, advocacy collaborations and a growing community of verified respondents extend reach while keeping consent and privacy intact.

To learn more, see how feasibility, fieldwork, and reporting connect across markets on the healthcare research methods overview.

rare disease recruitment in rare disease market rare disease market patient population and recruitment rare disease market research patient recruitment process rare disease patient recruitment challenges infographic

Conditions we recruit for

For instance, recent projects have included participants living with the following diagnoses, among many others:

  • Specifically, Fabry disease
  • Similarly, hemophilia A and B
  • Likewise, sickle cell disease
  • Additionally, hereditary angioedema
  • Furthermore, epidermolysis bullosa
  • Moreover, tuberous sclerosis complex
  • Also, alpha-mannosidosis
  • Notably, ocular myasthenia gravis
  • In the same way, polycythemia vera
  • Finally, idiopathic pulmonary fibrosis

Not seeing your indication listed? In that case, request a feasibility review — most assessments return within 3–5 business days when inclusion and exclusion rules are clear. Moreover, niche populations can often be evaluated quickly once screening logic is documented.

Planning a wider program? As such, the case studies page illustrates comparable engagements across therapeutic areas.

rare disease market patient recruitment workflow rare disease research recruitment process steps rare disease market participant recruitment process rare disease recruitment process with verification and compliance

How the recruitment process works

To keep projects efficient, rare disease recruitment follows a structured path from feasibility through delivery. In addition, related advisory and market research programs can reuse those same checkpoints end to end.

  1. Feasibility assessment. First, target condition, sample criteria, and study timelines are reviewed; a feasibility estimate typically arrives within 3–5 business days at no cost.
  2. Participant identification. Next, candidates are sourced through physician partnerships, patient advocacy channels, and verified respondent communities.
  3. Diagnosis verification. Then, every participant is confirmed via physician attestation, medical record review, or patient-portal validation — never self-report alone.
  4. Compliant data collection. After that, outreach, screening, and data handling follow HIPAA, GDPR, and ISO 20252 requirements to protect confidentiality.
  5. Delivery and reporting. Finally, qualified respondents arrive on schedule with quality checks and project management through closeout.

Frequently asked questions

How long does rare disease patient recruitment take?

Generally, most engagements finish within about two to four weeks after kickoff. Typically, feasibility memos return within 3–5 business days during the opening phase.

However, ultra-rare indications with extremely small pools may need extra calendar time — expectations are set upfront before fieldwork begins.

How do you verify that participants have the condition?

In practice, three verification paths are used, depending on the protocol: physician confirmation, documentation review, or patient-portal checks. In other words, self-reported diagnosis alone is never treated as sufficient evidence of eligibility.

Can you recruit both patients and caregivers?

Certainly — especially for pediatric or dependent populations, caregiver voices matter as much as patient narratives. Therefore, screening can target primary caregivers, co-caregivers, or other defined support roles when the brief requires it.

What types of research do you support?

For example, qualitative designs (depth interviews, focus groups), quantitative surveys, hybrids, and bespoke methodologies are all in scope. In addition, both one-off studies and longitudinal panels can be structured around the same verification standards.

Do you work internationally?

Moreover, global recruitment is available, with GDPR-aligned processes for European participants and localized expertise in priority markets. When needed, outreach tactics adapt to regional regulatory and cultural expectations without weakening compliance.

Compliance and data standards

Importantly, controls are embedded at every stage — from first contact and screening through verification, storage, and reporting.

HIPAA-aligned safeguards

Specifically, health information is handled under U.S. privacy expectations appropriate to the study design and data flows involved.

GDPR-aligned processing

Similarly, European participants receive processes mapped to GDPR obligations, including lawful bases, transparency, and data-subject rights.

ISO 20252 certification

Furthermore, market, opinion, and social research activities follow the ISO 20252 standard so procurement and quality teams share a common framework.

Physician-verified respondents

As a result, clinical confirmation steps reduce noise in small-N samples and protect the integrity of rare disease insights

Tell us about your study

Ready to assess feasibility for your study? We respond within 3–5 business days. Share your objectives and we’ll help you plan verified patient recruitment.

Request a feasibility assessment
View a case study